Ulipristal structure
|
Common Name | Ulipristal | ||
---|---|---|---|---|
CAS Number | 159811-51-5 | Molecular Weight | 433.582 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 638.5±55.0 °C at 760 mmHg | |
Molecular Formula | C28H35NO3 | Melting Point | 183.5-184.5ºC /Losartan/ | |
MSDS | N/A | Flash Point | 340.0±31.5 °C |
Use of UlipristalUlipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM). Ulipristal binds to the progesteron receptor, thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system[1]. |
Name | (8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one |
---|---|
Synonym | More Synonyms |
Description | Ulipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM). Ulipristal binds to the progesteron receptor, thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system[1]. |
---|---|
Related Catalog | |
In Vivo | Ulipristal (CDB 3236) may suppress the growth of uterine leiomyomatosis. By inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 638.5±55.0 °C at 760 mmHg |
Melting Point | 183.5-184.5ºC /Losartan/ |
Molecular Formula | C28H35NO3 |
Molecular Weight | 433.582 |
Flash Point | 340.0±31.5 °C |
Exact Mass | 433.261688 |
PSA | 57.61000 |
LogP | 3.86 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.613 |
Precursor 9 | |
---|---|
DownStream 1 | |
6J5J15Q2X8 |
Deacetyl CDB 2914 |
Ulipristal [USAN:INN:BAN] |
(11β)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione |
Ulipristal (USAN/INN) |
Ulipristal,11beta-[4-(N,N-diMethylaMino)-phenyl]-17alpha-hydroxy-19-norpregna-4,9-diene-3,20-dione |
Estra-4,9-dien-3-one, 17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-, (11β,17α)- |
Ulipristal |